Whitehawk Therapeutics (WHWK) Other financing activities (2016 - 2025)
Whitehawk Therapeutics (WHWK) reported Other financing activities of $5.5 million for Q4 2025, up 32741.18% year-over-year from N/an in Q4 2024, and up 216.92% quarter-over-quarter from -$4.7 million in Q2 2025.
Whitehawk Therapeutics (WHWK) Other financing activities (2016 - 2025) Analysis & Trends
Whitehawk Therapeutics (WHWK) has 9 years of Other financing activities data on file, last reported at $5.5 million in Q4 2025.
- Other financing activities for Q4 2025 came in at $5.5 million, up 32741.18% year-over-year; the trailing twelve-month figure through Mar 2026 was $803000.0 (down 83.35% YoY), and the FY2025 annual result was $5.6 million, changed N/A from the prior year.
- Other financing activities advanced to $5.5 million in Q4 2025 per WHWK's latest filing, from -$4.7 million in the prior quarter.
- Over five years, Other financing activities peaked at $5.5 million in Q4 2025 and troughed at -$4.7 million in Q2 2025.
- A 5-year average of $589800.0 and a median of $41500.0 in 2023 frame the typical range for Other financing activities.
- The sharpest annual moves came in 2024 and 2025: Other financing activities plunged 150.0% in 2024, then surged 32741.18% in 2025.
- A 5-year view of Other financing activities shows it stood at -$1000.0 in 2021, then jumped by 11500.0% to $114000.0 in 2022, then plunged by 70.18% to $34000.0 in 2023, then sank by 150.0% to -$17000.0 in 2024, then surged by 32741.18% to $5.5 million in 2025.
- Business Quant data shows WHWK's Other financing activities at $5.5 million in Q4 2025, -$4.7 million in Q2 2025, and $4.8 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Whitehawk Therapeutics | 310.18 Mn | 187.14 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 5.55 Mn |
| Dec 31, 2025 | 5.55 Mn |
| Jun 30, 2025 | -4.75 Mn |
| Jun 30, 2025 | -4.75 Mn |
| Mar 31, 2025 | 4.82 Mn |
| Mar 31, 2025 | 4.82 Mn |
| Dec 31, 2024 | -17,000.00 |
| Dec 31, 2024 | -17,000.00 |
| Sep 30, 2024 | 17,000.00 |
| Sep 30, 2024 | 17,000.00 |
| Dec 31, 2023 | 34,000.00 |
| Dec 31, 2023 | 34,000.00 |
| Sep 30, 2023 | 77,000.00 |
| Sep 30, 2023 | 77,000.00 |
| Jun 30, 2023 | 49,000.00 |
| Jun 30, 2023 | 49,000.00 |
| Dec 31, 2022 | 114,000.00 |
| Dec 31, 2022 | 114,000.00 |
| Sep 30, 2021 | -1,000.00 |
| Sep 30, 2021 | -1,000.00 |